Добавил:
Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз: Предмет: Файл:

Garrett R.H., Grisham C.M. - Biochemistry (1999)(2nd ed.)(en)

.pdf
Скачиваний:
231
Добавлен:
15.08.2013
Размер:
24.81 Mб
Скачать
(Adapted from

13.4 Recombinant DNA Technology: An Exciting Scientific Frontier

421

MMLV (retrovirus) DNA

gag pol env

Expression cassette

a

MMLV vector DNA

b

Expression cassette

Genome

c

Packaging cell line

Packaged retrovirus vector

d

 

Receptor

Viral RNA

 

RT

 

Integration Viral DNA

Expression cassette product

Target cell

FIGURE 13.23 Retrovirus-mediated gene delivery ex vivo. Retroviruses are RNA viruses that replicate their RNA genome by first making a DNA intermediate. The Maloney murine leukemia virus (MMLV) is the retrovirus used in human gene therapy. Deletion of the essential genes gag, pol, and env from MMLV makes it replication-deficient (so it can’t reproduce) (a) and creates a space for insertion of an expression cassette (b). The modified MMLV acts as a vector for the expression cassette; although replication-defective, it is still infectious. Infection of a packaging cell line that carries intact gag, pol, and env genes allows the modified MMLV to reproduce (c), and the packaged retroviral viruses can be collected and used to infect a patient (d). In the cytosol of the patient’s cells, a DNA copy of the viral RNA is synthesized by viral reverse transcriptase, which accompanies the viral RNA into the cells. This DNA is then randomly integrated into the host cell genome, where its expression leads to production of the expression cassette product.

Figure 1 in Crystal, R. G., 1995. Transfer of genes to humans: Early lessons and obstacles to success. Science 270:404.)

duce the desired gene product. Alternatively, adenovirus vectors that can carry expression cassettes up to 7.5 kb are a possible in vivo approach to human gene therapy (Figure 13.24). Recombinant, replication-deficient adenoviruses enter target cells via specific receptors on the target cell surface; the transferred genetic information is expressed directly from the adenovirus recombinant DNA and is never incorporated into the host cell genome. Although many problems remain to be solved, human gene therapy as a clinical strategy is feasible.

(Adapted from Figure 2 in Crystal, R. G., 1995. Transfer of genes to humans: Early
FIGURE 13.24

422 Chapter 13 Recombinant DNA: Cloning and Creation of Chimeric Genes

delete

Adenovirus DNA

E1 E3

a

Adenovirus vector DNA

Expression cassette

b

Complementing

cell line

c

Receptor

ExtrachromosomalDNA

 

d

Vesicle containing adenovirus vector

e Product of expression

cassette

Genome

Target cell

Adenovirus-mediated gene delivery in vivo. Adenoviruses are DNA viruses. The adenovirus genome (36 kb) is divided into early genes (E1 through E4) and late genes (L1 to L5) (a). Adenovirus vectors are generated by deleting gene E1 (and sometimes E3 if more space for an expression cassette is needed) (b); deletion of E1 renders the adenovirus incapable of replication unless introduced into a complementing cell line carrying the E1 gene (c). Adenovirus progeny from the complementing cell line can be used to infect a patient. In the patient, the adenovirus vector with its expression cassette enters the cells via specific receptors (d). Its linear dsDNA ultimately gains access to the cell nucleus, where it functions extrachromosomally and expresses the product of the expression cassette (e).

lessons and obstacles to success. Science 270:404.)

PROBLEMS

1.A DNA fragment isolated from an EcoRI digest of genomic DNA was combined with a plasmid vector linearized by EcoRI digestion so sticky ends could anneal. Phage T4 DNA ligase was then added to the mixture. List all possible products of the ligation reaction.

2.The nucleotide sequence of a polylinker in a particular plasmid vector is

OGAATTCCCGGGGATCCTCTAGAGTCGACCTGCAGGCATGCO

This polylinker contains restriction sites for BamHI, EcoRI, PstI, SalI, SmaI, SphI, and XbaI. Indicate the location of each restriction site in this sequence. (See Table 11.5 of restriction enzymes for their cleavage sites.)

3.A vector has a polylinker containing restriction sites in the following order: HindIII, SacI, XhoI, BglII, XbaI, and ClaI.

a. Give a possible nucleotide sequence for the polylinker.

b. The vector is digested with HindIII and ClaI. A DNA segment contains a HindIII restriction site fragment 650 bases upstream from a ClaI site. This DNA fragment is digested with HindIII and ClaI, and the resulting HindIII – ClaI fragment is directionally cloned into the HindIII – ClaI – digested vector. Give the nucleotide sequence at each end of the vector and the insert and show that the insert can be cloned into the vector in only one orientation.

4.Yeast (Saccharomyces cerevisiae) has a genome size of 1.21 107 bp. If a genomic library of yeast DNA was constructed in a bacteriophage vector capable of carrying 16-kbp inserts, how many indi-

vidual clones would have to be screened to have a 99% probability of finding a particular fragment?

5.The South American lungfish has a genome size of 1.02 1011 bp. If a genomic library of lungfish DNA was constructed in a cosmid vector capable of carrying inserts averaging 45 kbp in size, how many individual clones would have to be screened to have a 99% probability of finding a particular DNA fragment?

6.Given the following short DNA duplex of sequence (5 n3 )

ATGCCGTAGTCGATCATTACGATAGCATAGCACAGGGATCCACATGCACACACATGACATAGGACAGATAGCAT

what oligonucleotide primers (17-mers) would be required for PCR amplification of this duplex?

7. Figure 13.5b shows a polylinker that falls within the -galac- tosidase coding region of the lacZ gene. This polylinker serves as a cloning site in a fusion protein expression vector where the closed insert is expressed as a -galactosidase fusion protein. Assume the vector polylinker was cleaved with BamHI and then

FURTHER READING

Ausubel, F. M., Brent, R., Kingston, R. E., et al., eds., 1987. Current Protocols in Molecular Biology. New York: John Wiley & Sons. A popular cloning manual.

Berger, S. L., and Kimmel, A. R., eds., 1987. Guide to Molecular Cloning Techniques. Methods in Enzymology, Volume 152. New York: Academic Press.

Bolivar, F., Rodriguez, R. L., Greene, P. J., et al., 1977. Construction and characterization of new cloning vehicles. II. A multipurpose cloning system. Gene 2:95 – 113. A paper describing one of the early plasmid cloning systems.

Chalfie, M., et al., 1994. Green fluorescent protein as a marker for gene expression. Science 263:802 – 805.

Chien, C.-T., et al., 1991. The two-hybrid system: A method to identify and clone genes for proteins that interact with a protein of interest. Proceedings of the National Academy of Sciences U.S.A. 88:9578 – 9582.

Cohen, S. N., Chang, A. C. Y., Boyer, H. W., and Helling, R. B., 1973. Construction of biologically functional bacterial plasmids in vitro. Proceedings of the National Academy of Sciences U.S.A. 70:3240 – 3244. The classic paper on the construction of chimeric plasmids.

Cortese, R., 1996. Combinatorial Libraries: Synthesis, Screening and Application Potential. Berlin: Walter de Gruyter.

Crystal, R. G., 1995. Transfer of genes to humans: Early lessons and obstacles to success. Science 270:404 – 410.

Goeddel, D. V., ed., 1990. Gene Expression Technology. Methods in Enzymology,

Volume 185. New York: Academic Press.

Grunstein, M., and Hogness, D. S., 1975. Colony hybridization: A specific method for the isolation of cloned DNAs that contain a specific gene.

Proceedings of the National Academy of Sciences U.S.A. 72:3961 – 3965. Article describing the colony hybridization technique for specific gene isolation.

Guyer, M., 1992. A comprehensive genetic linkage map for the human genome. Science 258:67 – 86. M. Guyer is the corresponding author for the American/French NIH/CEPH (National Institutes of Health/Centre Etude du Polymorphisme Humain) Collaborative Mapping Group. This

Further Reading

423

ligated with an insert whose sequence reads

GATCCATTTATCCACCGGAGAGCTGGTATCCCCAAAAGACGGCC . . .

What is the amino acid sequence of the fusion protein? Where is the junction between -galactosidase and the sequence encoded by the insert? (Consult the genetic code table on the inside front cover to decipher the amino acid sequence.)

8. The amino acid sequence across a region of interest in a protein is

Asn-Ser-Gly-Met-His-Pro-Gly-Lys-Leu-Ala-Ser-Trp-Phe-Val-Gly-Asn-Ser

The nucleotide sequence encoding this region begins and ends with an EcoRI site, making it easy to clone out the sequence and amplify it by the polymerase chain reaction (PCR). Give the nucleotide sequence of this region. Suppose you wished to change the middle Ser residue to a Cys to study the effects of this change on the protein’s activity. What would be the sequence of the mutant oligonucleotide you would use for PCR amplification?

article is part of the October 2, 1992, issue of Science (Volume 258, Number 1), which presents an update of progress on the Human Genome Project. See also the 1995 genome issue of Science, Volume 270, Number 5235, October 20, 1995.

Jackson, D. A., Symons, R. H., and Berg, P., 1972. Biochemical method for inserting new genetic information into DNA of simian virus 40: Circular SV40 DNA molecules containing lambda phage genes and the galactose operon of E. coli. Proceedings of the National Academy of Sciences U.S.A.

69:2904 – 2909.

Luckow, V. A., and Summers, M. D., 1988. Trends in the development of baculovirus expression vectors. Biotechnology 6:47 – 55.

Lyon, J., and Gorner, P., 1995. Altered Fates. Gene Therapy and the Retooling of Human Life. New York: Norton.

Maniatis, T., Hardison, R. C., Lacy, E., et al., 1978. The isolation of structural genes from libraries of eucaryotic DNA. Cell 15:687 – 701.

Morgan, R. A., and Anderson, W. F., 1993. Human gene therapy. Annual Review of Biochemistry 62:191 – 217.

Murialdo, H., 1991. Bacteriophage lambda DNA maturation and packaging. Annual Review of Biochemistry 60:125 – 153. Review of the biochemistry of packaging DNA into phage heads.

Palese, P., and Roizman, B., 1996. Genetic engineering of viruses and of virus vectors: A preface. Proceedings of the National Academy of Sciences U.S.A.

93:11287 – 11425. A preface to a series of papers from a colloquium on genetic engineering and methods in gene therapy.

Peterson, K. R., et al., 1997. Production of transgenic mice with yeast artificial chromosomes. Trends in Genetics 13:61 – 66.

Saiki, R. K., Gelfand, D. H., Stoeffel, B., et al., 1988. Primer-directed amplification of DNA with a thermostable DNA polymerase. Science 239:487 – 491. Discussion of the polymerase chain reaction procedure.

Sambrook, J., Fritsch, E. F., and Maniatis, T., 1989. Molecular Cloning, 2nd ed. Long Island: Cold Spring Harbor Laboratory Press. (This cloning manual is familiarly referred to as “Maniatis.”)

424 Chapter 13 Recombinant DNA: Cloning and Creation of Chimeric Genes

Scriver, C. R., Beaudet, A. L., Sly, W. S., and Valle, D., eds. 1995. The Metabolic and Molecular Bases of Inherited Disease. The seventh edition of this classic work contains contributions from over 300 authors. A three-volume treatise, it is the definitive source on the molecular basis of inherited diseases.

Southern, E. M., 1975. Detection of specific sequences among DNA fragments separated by gel electrophoresis. Journal of Molecular Biology 98:503 – 517. The classic paper on the identification of specific DNA sequences through hybridization with unique probes.

Southern, E. M., 1996. DNA chips: Analysing sequence by hybridization to oligonucleotides on a large scale. Trends in Genetics 12:110 – 115.

Timmer, W. C., and Villalobos, J. M., 1993. The polymerase chain reaction.

The Journal of Chemical Education 70:273 – 280.

Young, R. A., and Davis, R. W., 1983. Efficient isolation of genes using antibody probes. Proceedings of the National Academy of Sciences U.S.A.

80:1194 – 1198. Using antibodies to screen protein expression libraries to isolate the structural gene for a specific protein.

Part II

Protein Dynamics

CHAPTER 14

Enzyme Kinetics

CHAPTER 15

Enzyme Specificity and Regulation

CHAPTER 16

Mechanisms of Enzyme Action

CHAPTER 17

Molecular Motors

Protein dynamics—the action of enzymes and molecular motors—provides the key to understanding the biochemistry of this cheetah and the grasses through which it runs.

(Frank Lane/Parfitt/Tony Stone Images)

“Now! Now!” cried the Queen. “Faster! Faster! . . . Now here, you see, it takes all the running you can do, to keep in the same place. If you want to get somewhere else, you must run at least twice as fast as that!”

LEWIS CARROLL, Alice’s Adventures in Wonderland (1865)

OUTLINE

14.1

Enzymes — Catalytic Power, Specificity,

 

 

and Regulation

14.2

Introduction to Enzyme Kinetics

14.3

Kinetics of Enzyme-Catalyzed Reactions

14.4

Enzyme Inhibition

14.5

Kinetics of Enzyme-Catalyzed Reactions

 

 

Involving Two or More Substrates

14.6

RNA and Antibody Molecules as

 

 

Enzymes: Ribozymes and Abzymes

426

Chapter 14

Enzyme Kinetics

“Alice and the Queen of Hearts,” illustrated by John Tenniel, The Nursery Alice. (Mary Evans Picture Library,

London)

Living organisms seethe with metabolic activity. Thousands of chemical reactions are proceeding very rapidly at any given instant within all living cells. Virtually all of these transformations are mediated by enzymes, proteins (and occasionally RNA) specialized to catalyze metabolic reactions. The substances transformed in these reactions are often organic compounds that show little tendency for reaction outside the cell. An excellent example is glucose, a sugar that can be stored indefinitely on the shelf with no deterioration. Most cells quickly oxidize glucose, producing carbon dioxide and water and releasing lots of energy:

C6H12O6 6 O2 88n 6 CO2 6 H2O 2870 kJ of energy

( 2870 kJ/mol is the standard free energy change [ G° ] for the oxidation of glucose; see Chapter 3). In chemical terms, 2870 kJ is a large amount of energy, and glucose can be viewed as an energy-rich compound even though at ambi-

FIGURE 14.2
FIGURE 14.1

14.1 Enzymes—Catalytic Power, Specificity, and Regulation

427

 

G, Free energy

 

 

of activation

 

G

 

G, Energy of activation

energy,

 

Glucose

with enzymes

 

 

 

Free

+ 6O2

 

 

G, Free energy

 

 

 

 

released

 

 

6CO2 + 6H2O

 

 

Progress of reaction

ent temperature it is not readily reactive with oxygen outside of cells. Stated another way, glucose represents thermodynamic potentiality: its reaction with oxygen is strongly exergonic, but it just doesn’t occur under normal conditions. On the other hand, enzymes can catalyze such thermodynamically favorable reactions so that they proceed at extraordinarily rapid rates (Figure 14.1). In glucose oxidation and countless other instances, enzymes provide cells with the ability to exert kinetic control over thermodynamic potentiality. That is, living systems use enzymes to accelerate and control the rates of vitally important biochemical reactions.

Reaction profile showing large Gfor glucose oxidation, free energy change of 2,870 kJ/mol; catalysts lower G, thereby accelerating rate.

Glucose

1 Hexokinase

Glucose-6-P

2 Phosphogluco-

isomerase

Fructose-6-P

3 Phosphofructokinase

Fructose-1,6-bis P

4 Aldolase

Glyceraldehyde–3-P Dihydroxyacetone-P

Enzymes Are the Agents of Metabolic Function

Acting in sequence, enzymes form metabolic pathways by which nutrient molecules are degraded, energy is released and converted into metabolically useful forms, and precursors are generated and transformed to create the literally thousands of distinctive biomolecules found in any living cell (Figure 14.2). Situated at key junctions of metabolic pathways are specialized regulatory enzymes capable of sensing the momentary metabolic needs of the cell and adjusting their catalytic rates accordingly. The responses of these enzymes ensure the harmonious integration of the diverse and often divergent metabolic activities of cells so that the living state is promoted and preserved.

14.1 Enzymes — Catalytic Power, Specificity, and Regulation

Enzymes are characterized by three distinctive features: catalytic power, specificity, and regulation.

Catalytic Power

Enzymes display enormous catalytic power, accelerating reaction rates as much as 1016 over uncatalyzed levels, which is far greater than any synthetic catalysts can achieve, and enzymes accomplish these astounding feats in dilute aqueous

6

5

Triose-P

isomerase

 

 

Glyceraldehyde-

3-P dehydrogenase

1,3-Bisphosphoglycerate

7 Phosphoglycerate

kinase 3-Phosphoglycerate

8

Phosphoglyceromutase

2-Phosphoglycerate

9

Enolase

Phosphoenolpyruvate

10

Pyruvate kinase

Pyruvate

The breakdown of glucose by glycolysis provides a prime example of a metabolic pathway. Ten enzymes mediate the reactions of glycolysis. Enzyme 4, fructose 1,6, biphosphate aldolase, catalyzes the COC bond – breaking reaction in this pathway.

FIGURE 14.3

428 Chapter 14 Enzyme Kinetics

solutions under mild conditions of temperature and pH. For example, the enzyme jack bean urease catalyzes the hydrolysis of urea:

 

 

O

 

 

 

H N

 

 

 

 

 

 

 

 

C

 

NH 2 H

O H 8n 2 NH

HCO

 

 

2

2

2

4

3

Percent yield

 

 

 

 

 

 

 

 

 

 

 

 

 

 

At 20°C, the rate constant for the enzyme-catalyzed reaction is 3 104/sec; the

 

 

 

 

 

 

 

 

 

 

 

 

 

 

rate constant for the uncatalyzed hydrolysis of urea is 3 10 10/sec. Thus, 1014

 

 

 

 

 

 

 

 

 

 

 

 

 

 

is the ratio of the catalyzed rate to the uncatalyzed rate of reaction. Such a

 

 

 

 

 

 

 

 

 

 

 

 

 

 

ratio is defined as the relative catalytic power of an enzyme, so the catalytic

 

 

 

 

 

 

 

 

 

 

 

 

 

 

power of urease is 1014.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Specificity

100

 

 

 

 

 

 

 

 

 

 

 

 

 

A given enzyme is very selective, both in the substances with which it interacts

 

 

100

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

and in the reaction that it catalyzes. The substances upon which an enzyme

 

 

 

90

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

acts are traditionally called substrates. In an enzyme-catalyzed reaction, none

 

 

 

 

 

 

 

 

 

 

 

 

 

 

75

 

 

 

81

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

of the substrate is diverted into nonproductive side-reactions, so no wasteful

 

 

 

 

 

72.9

 

 

 

 

 

 

 

 

 

 

 

 

 

 

65.6

 

 

 

 

 

 

by-products are produced. It follows then that the products formed by a given

50

 

 

 

 

 

 

 

59

 

 

 

 

 

enzyme are also very specific. This situation can be contrasted with your own

 

 

 

 

 

 

 

 

53

 

 

 

 

 

 

 

 

 

 

 

 

 

 

47.8

 

 

 

experiences in the organic chemistry laboratory, where yields of 50% or even

35

 

 

 

 

 

 

 

 

 

 

43

 

 

30% are viewed as substantial accomplishments (Figure 14.3). The selective

 

 

 

 

 

 

 

 

 

 

 

38.7

 

 

 

 

 

 

 

 

 

 

 

 

34.9

 

 

 

 

 

 

 

 

 

 

 

 

 

qualities of an enzyme are collectively recognized as its specificity. Intimate

25

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

interaction between an enzyme and its substrates occurs through molecular

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

recognition based on structural complementarity; such mutual recognition is

0

 

 

 

 

 

 

 

 

 

 

 

 

 

the basis of specificity. The specific site on the enzyme where substrate binds

 

 

 

 

 

 

 

 

 

 

 

 

 

0

1

2

3

4

5

6

7

8

9

10

and catalysis occurs is called the active site.

 

 

 

 

 

 

Reaction step

 

 

 

 

 

 

 

 

 

 

 

 

 

A 90% yield over 10 steps, for example, in a metabolic pathway, gives an overall yield of 35%. Therefore, yields in biological reactions must be substantially greater; otherwise, unwanted by-products would accumulate to unacceptable levels.

Regulation

Regulation of enzyme activity is achieved in a variety of ways, ranging from controls over the amount of enzyme protein produced by the cell to more rapid, reversible interactions of the enzyme with metabolic inhibitors and activators. Chapter 15 is devoted to discussions of enzyme regulation. Because most enzymes are proteins, we can anticipate that the functional attributes of enzymes are due to the remarkable versatility found in protein structures.

Enzyme Nomenclature

Traditionally, enzymes often were named by adding the suffix -ase to the name of the substrate upon which they acted, as in urease for the urea-hydrolyzing enzyme or phosphatase for enzymes hydrolyzing phosphoryl groups from organic phosphate compounds. Other enzymes acquired names bearing little resemblance to their activity, such as the peroxide-decomposing enzyme catalase or the proteolytic enzymes (proteases) of the digestive tract, trypsin and pepsin. Because of the confusion that arose from these trivial designations, an International Commission on Enzymes was established in 1956 to create a systematic basis for enzyme nomenclature. Although common names for many enzymes remain in use, all enzymes now are classified and formally named according to the reaction they catalyze. Six classes of reactions are recognized (Table 14.1). Within each class are subclasses, and under each subclass are subsubclasses within which individual enzymes are listed. Classes, subclasses, subsubclasses, and individual entries are each numbered, so that a series of four numbers serves to specify a particular enzyme. A systematic name, descriptive

14.1 Enzymes—Catalytic Power, Specificity, and Regulation

429

Table 14.1

Systematic Classification of Enzymes According to the Enzyme Commission

E.C. Number

Systematic Name and Subclasses

 

 

1

Oxidoreductases (oxidation – reduction reactions)

1.1

Acting on CHOOH group of donors

1.1.1

With NAD or NADP as acceptor

1.1.3

With O2 as acceptor

1.2

Acting on the C O group of donors

1.2.3

With O2 as acceptor

1.3

Acting on the CHOCH group of donors

1.3.1

With NAD or NADP as acceptor

2

Transferases (transfer of functional groups)

2.1

Transferring C-1 groups

2.1.1

Methyltransferases

2.1.2

Hydroxymethyltransferases and formyltransferases

2.1.3

Carboxyltransferases and carbamoyltransferases

2.2

Transferring aldehydic or ketonic residues

2.3

Acyltransferases

2.4

Glycosyltransferases

2.6

Transferring N-containing groups

2.6.1

Aminotransferases

2.7

Transferring P-containing groups

2.7.1

With an alcohol group as acceptor

3

Hydrolases (hydrolysis reactions)

3.1

Cleaving ester linkage

3.1.1

Carboxylic ester hydrolases

3.1.3

Phosphoric monoester hydrolases

3.1.4

Phosphoric diester hydrolases

4

Lyases (addition to double bonds)

4.1

CPC lyases

4.1.1

Carboxy lyases

4.1.2

Aldehyde lyases

4.2

CPO lyases

4.2.1

Hydrolases

4.3

CPN lyases

4.3.1

Ammonia-lyases

5

Isomerases (isomerization reactions)

5.1

Racemases and epimerases

5.1.3

Acting on carbohydrates

5.2

Cis-trans isomerases

6

Ligases (formation of bonds with ATP cleavage)

6.1

Forming COO bonds

6.1.1

Amino acid – RNA ligases

6.2

Forming COS bonds

6.3

Forming CON bonds

6.4

Forming COC bonds

6.4.1

Carboxylases

 

 

of the reaction, is also assigned to each entry. To illustrate, consider the enzyme that catalyzes this reaction:

ATP D-glucose 88n ADP D-glucose-6-phosphate

A phosphate group is transferred from ATP to the C-6-OH group of glucose, so the enzyme is a transferase (Class 2, Table 14.1). Subclass 7 of transferases is

430 Chapter 14 Enzyme Kinetics

enzymes transferring phosphorus-containing groups, and sub-subclass 1 covers those phosphotransferases with an alcohol group as an acceptor. Entry 2 in this sub-subclass is ATP: D-glucose-6-phosphotransferase, and its classification number is 2.7.1.2.

In use, this number is written preceded by the letters E.C., denoting the Enzyme Commission. For example, entry 1 in the same sub-subclass is E.C.2.7.1.1, ATP: D-hexose-6-phosphotransferase, an ATP-dependent enzyme that transfers a phosphate to the 6-OH of hexoses (that is, it is nonspecific regarding its hexose acceptor). These designations can be cumbersome, so in everyday usage, trivial names are employed frequently. The glucose-specific enzyme, E.C.2.7.1.2, is called glucokinase and the nonspecific E.C.2.7.1.1 is known as hexokinase. Kinase is a trivial term for enzymes that are ATP-dependent phosphotransferases.

Coenzymes

Many enzymes carry out their catalytic function relying solely on their protein structure. Many others require nonprotein components, called cofactors (Table 14.2). Cofactors may be metal ions or organic molecules referred to as coenzymes. Cofactors, because they are structurally less complex than proteins, tend to be stable to heat (incubation in a boiling water bath). Typically, proteins are denatured under such conditions. Many coenzymes are vitamins or contain vitamins as part of their structure. Usually coenzymes are actively involved in the catalytic reaction of the enzyme, often serving as intermediate carriers of functional groups in the conversion of substrates to products. In most cases, a coenzyme is firmly associated with its enzyme, perhaps even by covalent bonds, and it is difficult to

Table 14.2

Enzyme Cofactors: Some Metal Ions and Coenzymes and the Enzymes with Which They Are Associated

Metal Ions and Some

 

 

 

 

 

Enzymes That Require

 

Coenzymes Serving as Transient Carriers

Representative Enzymes

 

Them

 

of Specific Atoms or Functional Groups

Using Coenzymes

 

 

 

 

 

 

 

 

Metal

 

 

 

 

 

 

 

Ion

Enzyme

 

Coenzyme

Entity Transferred

 

 

 

 

 

 

 

Fe2 or

Cytochrome oxidase

 

Thiamine pyrophosphate (TPP)

Aldehydes

Pyruvate dehydrogenase

Fe3

Catalase

Flavin adenine dinucleotide (FAD)

Hydrogen atoms

Succinate dehydrogenase

 

Peroxidase

 

Nicotinamide adenine dinucleotide

Hydride ion (H )

Alcohol dehydrogenase

Cu2

Cytochrome oxidase

 

(NAD)

 

 

 

Zn2

DNA polymerase

Coenzyme A (CoA)

Acyl groups

Acetyl-CoA carboxylase

 

Carbonic anhydrase

Pyridoxal phosphate (PLP)

Amino groups

Aspartate

 

 

 

 

 

 

 

aminotransferase

 

Alcohol dehydrogenase

 

5 -Deoxyadenosylcobalamin (vitamin B12)

H atoms and alkyl groups

Methylmalonyl-CoA

 

 

 

 

 

 

 

mutase

Mg2

Hexokinase

 

 

 

 

 

 

Glucose-6-phosphatase

Biotin (biocytin)

CO2

Propionyl-CoA

 

 

 

 

 

 

 

carboxylase

Mn2

Arginase

 

Tetrahydrofolate (THF)

Other one-carbon groups

Thymidylate synthase

K

Pyruvate kinase

 

 

 

 

 

 

(also requires Mg2 )

 

 

 

 

 

Ni2

Urease

 

 

 

 

 

Mo

Nitrate reductase

 

 

 

 

 

Se

Glutathione peroxidase

 

 

 

 

 

 

 

 

 

 

 

 

 

Соседние файлы в предмете Химия